New drug breakthrough shows promise for AML patients

A researcher funded by the Leukaemia Foundation of Queensland, Dr Steven Lane, has been exploring a new drug that looks to be highly effective against acute myeloid leukaemia (AML) and may prevent patients relapsing.

Pre-clinical trials by Dr Lane's team at the at QIMR Berghofer Translational Leukaemia Research Laboratory, led by Claudia Bruedigam, found the drug imetelstat kills or impairs leukaemia progression.